The government has asked states to consider doing away with the requirement of US and European regulatory certification for equipment to be purchased for state-run institutions and hospitals. In a bid to promote the domestic pharmaceutical industry, it is recommended that there should be a preference for Make in India products during public procurement.
“Domestic manufacturers face discrimination even if they have India’s drug regulatory certification, at times. This is a clear indication that some states and institutions want to only favour MNCs,” opined a device manufacturer.
Stay ahead in the dynamic world of trade and commerce with India Business & Trade's weekly newsletter.